| Company Name |
Natco Pharma Ltd |
| Face Value |
2 |
| BSE Code |
524816 |
| Year End |
202603 |
| Full Year |
| Equity (Rs.Cr.) |
35.82 |
| B.V. Rs. |
477.50 |
| Sales Rs. Cr. |
3,594.60 |
| NP Rs. Cr. |
1,299.73 |
| NP Var% |
-26.00 |
| Div% |
250.00 |
| CPS Rs. |
83.20 |
| EPS Rs. |
72.60 |
| Traded Value(Rs.Lakhs) |
249.34 |
| 52 Week High |
1,226.00 |
| 52 Week Low |
789.00 |
| Price BSE |
817.00 |
| Price NSE |
816.00 |
| Market Capital(Rs. Cr.) |
14,624.32 |
| P/C Ratio |
9.80 |
| P/E Ratio |
11.30 |
| Price Vs.BV |
1.71 |
| Year End |
202606 |
| Sales Rs. Cr. |
596.60 |
| NP Rs. Cr. |
74.60 |
| NP Var % |
-84.00 |
| Year End |
202606 |
| Sales |
4,119.60 |
| OPM |
54.49 |
| NP |
1,838.50 |
| NP Var% |
-46.85 |
| EPS |
49.80 |
| PE |
16.40 |
|
|